FDA Office Of Generic Drugs Adding Fourth Team To Handle Increased ANDAs
Executive Summary
The Center for Drug Evaluation & Research Office of Generic Drugs is adding a fourth team within the Division of Bioequivalence to handle an increase in ANDA submissions, FDA said at a Drug Information Association meeting March 1 in Bethesda, Md